1. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Issue 10197 (10th August 2019) Authors: Tap, William D; Gelderblom, Hans; Palmerini, Emanuela; Desai, Jayesh; Bauer, Sebastian; Blay, Jean-Yves; Alcindor, Thierry; Ganjoo, Kristen; Martín-Broto, Javier; Ryan, Christopher W; Thomas, David M; Peterfy, Charles; Healey, John H; van de Sande, Michiel; Gelhorn, Heather L; Shuster, Dale E; Wa... Journal: Lancet Issue: Volume 394:Issue 10197(2019) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗